MediXall Group, Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7fca7973-5b0c-4417-9493-972e97dd89d0/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $309.4k | 2023-01-01 – 2023-12-31 | evidence 0001079973-25-000141 |
| FY 2022 | $59.3k | 2022-01-01 – 2022-12-31 | evidence 0001079973-23-001099 |
| FY 2021 | $180.7k | 2021-01-01 – 2021-12-31 | evidence 0001079973-22-000448 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001079973-22-000448 |
| FY 2019 | $2.7k | 2019-01-01 – 2019-12-31 | evidence 0001553350-20-000442 |
| FY 2018 | $1.9k | 2018-01-01 – 2018-12-31 | evidence 0001553350-19-000563 |
| FY 2017 | $22.2k | 2017-01-01 – 2017-12-31 | evidence 0001553350-18-000182 |
| FY 2013 | $42.5k | 2013-01-01 – 2013-12-31 | evidence 0001553350-15-000404 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).